• MPhil, MSc (Biochemistry), BSc (Microbiology), Diploma in Management Level 5, PRINCE2 Foundation and NEBOSH Certificate.
• Core Facilities Manager – Biomedical Research Centre, Guys and St Thomas NHS Foundation Trust
• Operations and Safety Coordinator – Division of Cancer, Imperial College London
• Programme Manager – Department of Immunology, Imperial College London
• Higher Scientific Officer – Chester Beatty Laboratories, Institute of Cancer Research
• Senior Research Technician – International Livestock Research Institute (Kenya)

• Operational management of School’s technical staff, laboratories and clinical teaching spaces

• Extensive experience in scientific research and management
• Research experience in a broad spectrum of disciplines including Cell Biology, Molecular Biology, Immunology, Protein Biochemistry and Parasite Biology
• Strategic and operational management of infrastructure support in research and teaching environments with a strong focus on service delivery
• Substantial experience in financial management, project management, people management, procurement and Health & Safety

• Delikouras, A., Hayes, M., Malde, P., Lechler, R.I. and Dorling, A. (2001).  Nitric oxide-mediated expression of Bcl-2 and Bcl-xl and protection from TNFa-mediated apoptosis in porcine endothelial cells after exposure to low concentration of xenoreactive natural antibody. Transplantation. 71, 599-605.
• Vaughan, A.N., Malde, P., Rogers, N.J., Jackson, I.M., Lechler, R.I. and Dorling, A.  (2000).  Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically supresses human CD4⁺ T cell responses co-stimulated by porcine but not human B7. J. Immunol. 165, 3175-3181.
• Mary K. L. Collins., Isla J. Furlong., Prupti Malde., Javier Oliver and Abelardo Lopez Rivas. (1996). An apoptotic endonuclease which can be activated either by decreasing pH or by increasing calcium. J. Cell Science. 109, 2393-2399.
• Malde, P and Collins, M.K.L.  (1994).  Disregulation of Myc expression in murine bone marrow cells results in an inability to proliferate in sub-optimal growth factor and an increased sensitivity to DNA damage. Int. Immunol. 6, 1169-1176.
• Collins, M.K.L., Marvel, J., Malde, P. and Lopez-Rivas, A.  (1992). Interleukin-3 protects Murine Bone Marrow cells from Apoptosis induced by DNA damaging agents. J. Exp. Med.  176, 1043-1051.
• Rodriguez-Tarduchy, G., Malde, P., Lopez-Rivas, A. and Collins, M.K.L.  (1992). Inhibition of apoptosis by calcium Ionophores in IL3 - Dependent bone marrow cells is dependent upon production of IL4. J. Immunol. 148, 1416-1422.
• Collins, M.K.L., Malde, P., Miyajima, A., Arai K-I., Smith, K.A. and Mulligan, R.C. (1990).  Evidence that the p55 component of the interleukin-2 receptor can confer IL2 responsiveness to a murine IL3 dependent cell. Eur. J. Immunol. 20, 573-578.

Professional Membership

Fellow of Institute of Science and Technology